MARKET

BFRI

BFRI

Biofrontera Inc
NASDAQ
0.7063
-0.0307
-4.17%
Closed 16:00 12/23 EST
OPEN
0.7500
PREV CLOSE
0.7370
HIGH
0.7500
LOW
0.7006
VOLUME
80.33K
TURNOVER
--
52 WEEK HIGH
1.870
52 WEEK LOW
0.5360
MARKET CAP
8.23M
P/E (TTM)
-0.3829
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BFRI last week (1215-1219)?
Weekly Report · 1d ago
Biofrontera Transfers Of Ameluz, RhodoLED New Drug Applications, Investigational New Drug Applications; Completes Requirements For Transfer Of All U.S., Some Global Intellectual Property Associated With Ameluz And RhodoLED
Benzinga · 5d ago
Biofrontera completes transfer of Ameluz, RhodoLED FDA approval
TipRanks · 5d ago
Biofrontera Inc. Secures Full Rights to Ameluz and RhodoLED Portfolio
Reuters · 5d ago
BIOFRONTERA INC. COMPLETES TRANSFER OF AMELUZ® AND RHODOLED® FDA APPROVAL AND ASSOCIATED INTELLECTUAL PROPERTY PORTFOLIO
Reuters · 5d ago
Weekly Report: what happened at BFRI last week (1208-1212)?
Weekly Report · 12/15 10:44
Weekly Report: what happened at BFRI last week (1201-1205)?
Weekly Report · 12/08 10:42
Biofrontera completes final patient visit in Phase 1 PK study of Ameluz gel
TipRanks · 12/04 14:15
More
About BFRI
Biofrontera Inc. is a biopharmaceutical company. The Company specializes in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT). The PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses of mild-to-moderate severity on the face and scalp. The Company’s primary licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (the RhodoLED Lamps), are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions. The Company commercializes the drug-device combination Ameluz with the RhodoLED lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. Its belixos ACTIVE CARE is a skin-soothing care foam for irritated and itchy skin, which can be used as basic care for atopic dermatitis and psoriasis as well as for soothing intensive care for everyday skin problems.

Webull offers Biofrontera Inc stock information, including NASDAQ: BFRI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BFRI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BFRI stock methods without spending real money on the virtual paper trading platform.